IOVANCE BIOTHERAPEUTICS INC (IOVA)
US4622601007 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.189M | 164.78M 13,758.70% | 447.61M 171.64% | 710.27M 58.68% | 1.026B 44.45% | 1.318B 28.46% | 1.54B 16.84% | 1.778B 15.45% | 2.036B 14.51% | |||
| EBITDA YoY % growth | -339.59M -30.21% | -389.57M -14.72% | -439.142M -12.72% | -380.318M 13.40% | -259.336M 31.81% | -128.59M 50.42% | -154.938M -20.49% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -342.7M -30.83% | -398.88M -16.39% | -460.559M -15.46% | -400.705M 13.00% | -264.873M 33.90% | -60.197M 77.27% | 153.48M 354.96% | 398.5M 159.64% | 578.99M 45.29% | 745.93M 28.83% | 993.83M 33.23% | |
| Operating Margin | N/A | N/A | -38,734.99% | -243.18% | -59.18% | -8.48% | 14.96% | 30.24% | 37.60% | 41.95% | 48.81% | |
| EPS YoY % growth | -2.22 -17.46% | -2.48 -11.71% | -1.88 24.19% | -1.29 31.48% | -0.80 37.67% | -0.25 69.38% | 0.48 296.68% | 0.98 103.23% | 1.15 17.31% | 1.23 7.08% | 1.43 15.70% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 40.09% | -0.23 44.14% | -0.21 38.00% | -0.19 31.19% | -0.24 10.61% |
| Revenue Q2Q % growth | 73.735M 15,197.72% | 83.035M 11,513.29% | 98.262M 215.89% | 115.46M 97.18% | 131.46M 78.29% |
| EBITDA Q2Q % growth | -86.057M 13.80% | -72.481M 34.17% | -82.936M 3.37% | -93.942M -45.83% | -102.704M -19.34% |
| EBIT Q2Q % growth | -84.387M 30.41% | -86.336M 26.66% | -79.679M 21.82% | -76.212M 14.43% | -74.675M 11.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.28 39.13% | -0.31 | 0.03 | 8.26% |
| Q2 2024 Q2Q % growth | -0.34 27.66% | -0.36 | 0.02 | 5.66% |
| Q1 2024 Q2Q % growth | -0.42 16.00% | -0.43 | 0.01 | 2.54% |
| Q4 2023 Q2Q % growth | -0.45 29.69% | -0.44 | -0.01 | -2.23% |
| Q3 2023 Q2Q % growth | -0.46 26.98% | -0.46 | 0.00 | 0.73% |
| Q2 2023 Q2Q % growth | -0.47 25.40% | -0.81 | 0.34 | 42.15% |
| Q1 2023 Q2Q % growth | -0.50 13.79% | -0.76 | 0.26 | 34.19% |
| Q4 2022 Q2Q % growth | -0.64 -1.59% | -0.65 | 0.01 | 1.52% |
| Q3 2022 Q2Q % growth | -0.63 -14.55% | -0.65 | 0.02 | 3.17% |
| Q2 2022 Q2Q % growth | -0.63 -18.87% | -0.62 | -0.01 | -1.85% |
| Q1 2022 Q2Q % growth | -0.58 -13.73% | -0.65 | 0.07 | 10.65% |
| Q4 2021 Q2Q % growth | -0.63 -34.04% | -0.57 | -0.06 | -10.72% |
| Q3 2021 Q2Q % growth | -0.55 -37.50% | -0.54 | -0.01 | -2.01% |
| Q2 2021 Q2Q % growth | -0.53 -12.77% | -0.52 | -0.01 | -1.46% |
| Q1 2021 Q2Q % growth | -0.51 7.27% | -0.50 | -0.01 | -2.79% |
| Q4 2020 Q2Q % growth | -0.47 6.00% | -0.45 | -0.02 | -4.13% |
| Q3 2020 Q2Q % growth | -0.40 | -0.47 | 0.07 | 14.90% |
| Q2 2020 Q2Q % growth | -0.47 -23.68% | -0.54 | 0.07 | 12.37% |
| Q1 2020 Q2Q % growth | -0.55 -83.33% | -0.52 | -0.03 | -5.90% |
| Q4 2019 Q2Q % growth | -0.50 | -0.42 | -0.08 | -18.12% |
| Q3 2019 Q2Q % growth | -0.40 | -0.40 | 0.00 | 0.58% |
| Q2 2019 Q2Q % growth | -0.38 | -0.30 | -0.08 | -27.98% |
| Q1 2019 Q2Q % growth | -0.30 | -0.29 | -0.01 | -3.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 58.555M 12,385.07% | 54.884M | 3.671M | 6.69% |
| Q2 2024 Q2Q % growth | 31.106M 12,969.75% | 25.08M | 6.026M | 24.03% |
| Q1 2024 Q2Q % growth | 715K | 2.117M | -1.402M | -66.23% |
| Q4 2023 Q2Q % growth | 482K | 1.419M | -937K | -66.03% |
| Q3 2023 Q2Q % growth | 469K | 4.276M | -3.807M | -89.03% |
| Q2 2023 Q2Q % growth | 238K | 3.655M | -3.417M | -93.49% |
| Q1 2023 Q2Q % growth | 204K | -204K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.44% | 0% | 1.79% |
| Revenue | 0% | -5.17% | 0% | -0.56% |